Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31775
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAdemi, Zanfina-
dc.contributor.authorMarquina, Clara-
dc.contributor.authorPerucca, Piero-
dc.contributor.authorHitchcock, Alison-
dc.contributor.authorGraham, Janet-
dc.contributor.authorEadie, Mervyn J-
dc.contributor.authorLiew, Danny-
dc.contributor.authorO'Brien, Terence J-
dc.contributor.authorVajda, Frank J-
dc.date2022-
dc.date.accessioned2023-01-12T03:02:33Z-
dc.date.available2023-01-12T03:02:33Z-
dc.date.issued2023-03-07-
dc.identifier.citationNeurology 2023; 100(10)en_US
dc.identifier.issn1526-632X-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31775-
dc.description.abstractThe Raoul Wallenberg Australian Pregnancy Register (APR) was established to collect, analyse and publish data on the risks to babies exposed to anti-seizure medications (ASMs), and to facilitate quality improvements in management care over time. It is one of several prospective observational pregnancy registers of ASMs that has been established around the world. While the APR and other registries have contributed to knowledge gain that has been applied to decrease adverse pregnancy outcomes, their cost-effectiveness remains unknown. Here we aimed to evaluate the economic impacts of the APR from both societal and healthcare system perspectives.en_US
dc.language.isoeng-
dc.titleEconomic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleNeurologyen_US
dc.identifier.affiliationCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australiaen_US
dc.identifier.affiliationEpilepsy Research Centreen_US
dc.identifier.affiliationDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Neurology, The Royal Melbourne Hospital, Melbourne, Australia.en_US
dc.identifier.affiliationNeurologyen_US
dc.identifier.affiliationDepartment of Medicine, The University of Queensland, Brisbane, Australia.en_US
dc.identifier.affiliationSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.en_US
dc.identifier.doi10.1212/WNL.0000000000201655en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-0625-3522en_US
dc.identifier.orcid0000-0002-7855-7066en_US
dc.identifier.orcid0000-0001-5570-7538en_US
dc.identifier.pubmedid36460471-
local.name.researcherPerucca, Piero
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptNeurology-
crisitem.author.deptComprehensive Epilepsy Program-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

42
checked on Nov 7, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.